Traws Pharma Stock Analysis

Traws Stock Analysis Notes

About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.67. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Traws Pharma recorded a loss per share of 5.95. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 21st of May 2021. To find out more about Traws Pharma contact Werner Cautreels at 267 759 3680 or learn more at https://www.trawspharma.com.

Traws Pharma Investment Alerts

Traws Largest EPS Surprises

View All Earnings Estimates

Traws Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.85 M.

Traws Profitablity

Management Efficiency

Traws Pharma has return on total asset (ROA) of (0.5251) % which means that it has lost $0.5251 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.9652) %, meaning that it created substantial loss on money invested by shareholders. Traws Pharma's management efficiency ratios could be used to measure how well Traws Pharma manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.79 in 2025. Return On Capital Employed is likely to climb to -1.65 in 2025. At this time, Traws Pharma's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to climb to about 2.2 M in 2025, whereas Non Currrent Assets Other are likely to drop 855.00 in 2025.

Technical Drivers

As of the 1st of February, Traws Pharma has the Coefficient Of Variation of 1145.47, risk adjusted performance of 0.0825, and Semi Deviation of 7.05. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Traws Pharma, as well as the relationship between them. Please validate Traws Pharma mean deviation, information ratio, as well as the relationship between the Information Ratio and downside variance to decide if Traws Pharma is priced more or less accurately, providing market reflects its prevalent price of 7.17 per share. Given that Traws Pharma has jensen alpha of 1.49, we advise you to double-check Traws Pharma's current market performance to make sure the company can sustain itself at a future point.

Traws Pharma Price Movement Analysis

Traws Pharma Insider Trading Activities

Traws Pharma Predictive Daily Indicators

Traws Pharma Forecast Models

Traws Pharma's time-series forecasting models are one of many Traws Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Traws Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Traws Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Traws shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Traws Pharma. By using and applying Traws Stock analysis, traders can create a robust methodology for identifying Traws entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Traws analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Traws analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Traws Pharma stock analysis indicators help investors evaluate how Traws Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Traws Pharma shares will generate the highest return on investment. By understating and applying Traws Pharma stock analysis, traders can identify Traws Pharma position entry and exit signals to maximize returns.

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.